Actively Recruiting
Evaluation of Postoperative Pain and Substance P Levels Comparing Bioceramic and Calcium Hydroxide Intracanal Medicaments in Permanent Mandibular Molars with Symptomatic Apical Periodontitis
Led by Future University in Egypt · Updated on 2026-09-25
28
Participants Needed
1
Research Sites
N/A
Total Duration
AI-Summary
What This Trial Is About
Researchers are evaluating postoperative pain and Substance P levels in patients with symptomatic apical periodontitis affecting permanent mandibular molars. The study compares two intracanal medicaments bioceramic material and calcium hydroxide. This research aims to understand which medicament better reduces pain and inflammation after root canal treatment, potentially improving endodontic therapy decisions. A total of 28 patients will be randomly assigned to two groups of 14 participants each. One group will receive calcium hydroxide, while the other will receive a bioceramic intracanal medicament. Standardized root canal procedures will be performed for all, followed by assessment of pain using a visual analog scale at multiple time points. Samples will be collected to measure Substance P as a marker of pain and inflammation. Participants will undergo treatment and post-treatment evaluations lasting one week. Researchers will monitor postoperative pain levels and Substance P expression. The study includes collection of biochemical samples and pain assessments to compare the effects of the two medicaments. Participation involves clinical visits for treatment and follow-up, with the overall goal of improving pain management after endodontic procedures.
CONDITIONS
Brief Title
Postoperative Pain and Substance P Levels After Bioceramic vs Calcium Hydroxide Intracanal Medicaments in Symptomatic Apical Periodontitis
Research Team
S
Salma Tarek Abdullah, Bachelors degree
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here